E Schraven
Impact in
- Clinical Biochemistry top 10%
- Advanced Glycation End Products research
- Organic Chemistry top 10%
- Multicomponent Synthesis of Heterocycles
- Synthesis and biological activity
- Microwave-Assisted Synthesis and Applications
- Synthesis and Biological Evaluation
- Chemical Synthesis and Reactions
Papers in
-
- Phosphodiesterase function and regulation 3
- Enzyme function and inhibition 3
- Receptor Mechanisms and Signaling 2
- Chemical Synthesis and Analysis 2
- Co-authors
- Karl Schönafinger (1 shared paper)Bernd Jablonka (1 shared paper)Raimund Mannhold (1 shared paper)Peter Riederer (1 shared paper)F W Koss (1 shared paper)D. Palm (1 shared paper)G Beisenherz (1 shared paper)Ursula Schindler (1 shared paper)
- Journals
- Xenobiotica (2 papers)European Journal of Medicinal Chemistry (1 paper)Cellular and Molecular Life Sciences (1 paper)European Journal of Pharmacology (1 paper)Naunyn-Schmiedeberg s Archives of Pharmacology (1 paper)
- Partner nations
- GermanyUnited Kingdom
In The Last Decade
E Schraven
19 papers receiving 320 citations
Peers
Comparison fields: 5 of 73
- Clinical Biochemistry 45
- Organic Chemistry 179
- Chemical Health and Safety 2
- Physiology 66
- Biochemistry 16
Countries citing papers authored by E Schraven
This map shows the geographic impact of E Schraven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Schraven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Schraven more than expected).
Fields of papers citing papers by E Schraven
This network shows the impact of papers produced by E Schraven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Schraven. The network helps show where E Schraven may publish in the future.
Co-authors
The 25 scholars most cited alongside E Schraven, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 159 | |
| 2 | 1994 | 62 | |
| 3 | 1967 | 34 | |
| 4 | On the mechanism of the antagonistic action of xanthine derivatives against adenosine and coronary vasodilators. | 1972 | 21 |
| 5 | 1987 | 11 | |
| 6 | 1986 | 9 | |
| 7 | 1968 | 7 | |
| 8 | Absorption and disposition of [14C]-molsidomine in laboratory animals. | 1981 | 7 |
| 9 | 1983 | 6 | |
| 10 | [Regulation of lipid and carbohydrate metabolism of the heart by carbocromen (author's transl)]. | 1976 | 5 |
| 11 | 1962 | 4 | |
| 12 | Influence of carbocromene on free fatty acid metabolism of the heart. | 1978 | 4 |
| 13 | [HPLC determination of troxerutin in plasma and urine following oral administration in man]. | 1985 | 4 |
| 14 | [Inhibition of monoamine oxidase A and B in the heart and brain of the rat with amitriptyline, pargyline and pirlindol]. | 1984 | 3 |
| 15 | Effects of a chronic administration of the new antidepressant pirlindole on biogenic amine receptors in rat prefrontal cortex and hippocampus. Comparison with desipramine, nomifensine and zimelidine. | 1990 | 3 |
| 16 | [The effect of carbocromen on cardiac cyclic adenosine-monophosphate]. | 1976 | 2 |
| 17 | [Blood levels, distribution in the organs and excretion of carbochromen in rat, dog and man]. | 1970 | 2 |
| 18 | Vitamin D-induced myocardial lesions and the protection by carbocromen. | 1982 | 2 |
| 19 | 1964 | 1 | |
| 20 | [Percutaneous absorption of heparin- 35 S from a specially prepared oil-in-water emulsion]. | 1973 | 1 |
About E Schraven
E Schraven is a scholar working on Molecular Biology, Organic Chemistry, Biochemistry, Pharmacology and Pharmacology, having authored 23 papers that have together received 347 indexed citations. Recurring topics across this work include Phosphodiesterase function and regulation (3 papers), Amino Acid Enzymes and Metabolism (3 papers), Enzyme function and inhibition (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Receptor Mechanisms and Signaling (2 papers), Chemical Synthesis and Analysis (2 papers), Vitamin D Research Studies (2 papers) and Natural Antidiabetic Agents Studies (2 papers). The work is most often cited by research in Clinical Biochemistry (45 citations), Organic Chemistry (179 citations), Chemical Health and Safety (2 citations), Physiology (66 citations) and Biochemistry (16 citations). E Schraven has collaborated with scholars based in Germany and United Kingdom. Frequent co-authors include Karl Schönafinger, Bernd Jablonka, Raimund Mannhold, Peter Riederer, F W Koss, D. Palm, G Beisenherz, Ursula Schindler, Reinhard Schinzel and Gerald Münch. Their work appears in journals such as Xenobiotica, European Journal of Medicinal Chemistry, Cellular and Molecular Life Sciences, European Journal of Pharmacology and Naunyn-Schmiedeberg s Archives of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.